CURE Pharmaceutical Competitors and Similar CompaniesClear all

CURE Pharmaceutical's competitors and similar companies include Biogen.
CURE Pharmaceutical
CURE Pharmaceutical
CURE Pharmaceutical is a drug delivery and development company.
Biogen
Biogen
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
Founding Date
Founding Date
2011
Founding Date
1978
Type
Type
Public
Type
Public
Tags
Locations
Locations
Oxnard, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
São Paul, BR
Toronto, CA
see more
Employees
Employees
15
Employees
7,605
Valuation ($)
Valuation ($)
104.7 m
Valuation ($)
26.7 b

Financial

Revenue (est.)
Revenue (est.)
$4.3m (FY, 2023)
Revenue (est.)
$9.9b (FY, 2025)
Cost of goods
Cost of goods
$1.2m (FY, 2023)
Cost of goods
$2.4b (FY, 2025)
Gross profit
Gross profit
$3.1m (FY, 2023)
Gross profit
$7.5b (FY, 2025)
Net income
Net income
($3.4m) (FY, 2023)
Net income
$1.3b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Biogen
HQ
Cambridge, US
Employees
7,605

Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.

View company